InspireMD establishes Miami global HQ; anticipates U.S. launch of CGuard Prime in H1 2025

InspireMD, Inc.

New global headquarters in Miami, Florida to support anticipated U.S. launch of CGuard Prime carotid stent system.
Company expects potential FDA approval and U.S. launch in first half of 2025.
Lease for 10,782 sq ft office space with 64-month term; $500,000 security deposit.
Building commercial teams and infrastructure to support U.S. market.
Submitted final module of PMA to FDA on September 16, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.